Cite
HARVARD Citation
Lowe, J. et al. (2020). Mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophy. ESC heart failure. pp. 3983-3995. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lowe, J. et al. (2020). Mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophy. ESC heart failure. pp. 3983-3995. [Online].